Back to SNDX
Assenagon Asset Management S.A. → SNDX
Assenagon Asset Management S.A. SNDX Position History
Syndax Pharmaceuticals, Inc. • Healthcare
Quarters held
6
Latest value
$785K
Q3 2026
Peak value
$27.4M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $27.4M |
| Q4 2025 | $877K |
| Q1 2026 | $975K |
| Q2 2026 | $912K |
| Q2 2026 | $912K |
| Q3 2026 | $785K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $785K | 41.7K | — | — |
| Q2 2026 | $912K | 41.7K | — | — |
| Q2 2026 | $912K | 41.7K | — | — |
| Q1 2026 | $975K | 41.7K | — | — |
| Q4 2025 | $877K | 41.7K | — | — |
| Q3 2025 | $27.4M | 1.78M | — | — |
Other funds holding SNDX
$123.7M
$123.7M
$118.9M
$116.1M
$114.7M
$114.2M
$114.2M
$111.4M